IB

Installed Building Products, Inc.

IBPConsumer CyclicalNASDAQ

Residential Construction

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$2.97B
+1.0% YoY
Net Income
$265.4M
+3.4% YoY
EBITDA
$533.6M
+3.1% YoY
Free Cash Flow
$317.2M

Scan Results

Daily timeframe
DateIndicatorDetails
Jun 29 RSI OverboughtRSI 71.0, above 70, stock may be overbought
Jun 1 MACD Positive CrossoverHistogram +0.9088, positive momentum
About Installed Building Products, Inc.

Installed Building Products, Inc., together with its subsidiaries, engages in the installation of insulation for residential and commercial builders in the United States. At a $6.16B market cap, Installed Building Products, Inc. ranks as a mid-cap company within consumer cyclical. It operates through three segments: Installation, Distribution, and Manufacturing Operations.

Key stats
Market Cap$6.16B
P/E (TTM)24.40
Fwd P/E20.43
EPS$9.37
Beta1.71
52W Change+24.2%
Dividend Yield1.41%
ROE38.4%
Analysis

On the balance sheet, IBP has $474.3M in cash with $1.18B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. The company generates $317.2M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. Return on equity stands at 38.4%, which is exceptionally high for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Return on assets of 11.1% further supports the picture of efficient asset utilization. Revenue has been uneven over recent years, ranging from $2.67B to $2.97B.

Installed Building Products, Inc.'s elevated beta suggests the stock experiences more pronounced price movements than the overall market, which increases both upside potential and downside risk. No single metric tells the full story. Reviewing IBP's risk profile alongside its fundamentals and technical indicators provides a more complete picture.

Links
More Consumer Cyclical stocks
Browse all stocks →
Not financial advice. Scanance is an educational tool. Past performance does not guarantee future results.PrivacyTerms